Literature DB >> 27065211

Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients.

Zhu Cui1, Jason D Wright2,3, Melissa K Accordino2,4, Donna Buono1, Alfred I Neugut1,2,4, Jim C Hu5, Dawn L Hershman1,2,4.   

Abstract

Image-guided percutaneous liver biopsy (PLB) is a diagnostic tool for lesions in the liver. Hemorrhage is the most common complication. We selected patients with a diagnostic claim for cancer who had undergone PLB. There were a total of 26,941 patients who underwent PLB. Hemorrhage risk was 1.43% among patients undergoing PLB. When stratified by setting, odds of hemorrhage were 4.5 times higher when biopsy was performed in an inpatient setting (p < .001). Risk factors associated with hemorrhage included marital status, liver cancer and comorbidity score. The use of PLB has increased over time. Reassuringly, the hemorrhage risk associated with PLB is low.

Entities:  

Keywords:  Health sciences research; Imaging; Outcomes research

Mesh:

Year:  2016        PMID: 27065211      PMCID: PMC5002313          DOI: 10.3109/07357907.2016.1166232

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  26 in total

1.  Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Michael B Rothberg; Penelope S Pekow; Maureen Lahti; Oren Brody; Daniel J Skiest; Peter K Lindenauer
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  The value of fine needle aspiration biopsy in the diagnosis of metastatic liver tumours.

Authors:  Işin Soyuer; Cemil Ekinci; Muhsin Kaya; Kadir Bahar
Journal:  Turk J Gastroenterol       Date:  2002-06       Impact factor: 1.852

3.  Liver biopsy.

Authors:  Don C Rockey; Stephen H Caldwell; Zachary D Goodman; Rendon C Nelson; Alastair D Smith
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

4.  A 21-year experience with major hemorrhage after percutaneous liver biopsy.

Authors:  D B McGill; J Rakela; A R Zinsmeister; B J Ott
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

5.  Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer.

Authors:  D L Hershman; C A Richards; K Kalinsky; E T Wilde; Y S Lu; J A Ascherman; A I Neugut; J D Wright
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

6.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

7.  Reduced mortality rates following elective percutaneous liver biopsies.

Authors:  Joe West; Timothy R Card
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

8.  Liver biopsy: blind or guided?

Authors:  G Vautier; B Scott; D Jenkins
Journal:  BMJ       Date:  1994-12-03

9.  Trends in use and safety of image-guided transthoracic needle biopsies in patients with cancer.

Authors:  Melissa K Accordino; Jason D Wright; Donna Buono; Alfred I Neugut; Dawn L Hershman
Journal:  J Oncol Pract       Date:  2015-01-20       Impact factor: 3.840

10.  Percutaneous pancreaticobiliary biopsies in 173 patients using primarily ultrasound or fluoroscopic guidance.

Authors:  S K Teplick; P H Haskin; T S Kline; J K Sammon; P A Laffey
Journal:  Cardiovasc Intervent Radiol       Date:  1988       Impact factor: 2.740

View more
  2 in total

1.  Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study.

Authors:  Alfred I Neugut; Xiaobo Zhong; Benjamin Lebwohl; Grace C Hillyer; Melissa K Accordino; Jason D Wright; Ravi P Kiran; Dawn L Hershman
Journal:  Therap Adv Gastroenterol       Date:  2018-03-26       Impact factor: 4.409

2.  Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma.

Authors:  J Milburn Jessup; Mohamed Kabbout; Nikolay Korokhov; Alex Joun; Ann E Tollefson; William S M Wold; Abid R Mattoo
Journal:  Hum Vaccin Immunother       Date:  2019-10-21       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.